ACE2 and COVID-19: In this context, ACE2 levels among cancer subtypes may influence COVID-19 susceptibility, and bioinformatic data showed an increased level of mRNA expression of both ACE2 and TMPRSS2 in colorectal and lung cancers, which were found to be more susceptible to COVID-19 [20].